[Gln4]-Neurotensin
[Gln4]-Neurotensin is an amide analog that releases luteinizing hormone and follicle-stimulating hormone.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 61445-54-3
- Fòrmula: C78H122N22O19
- Peso molecular:1671.94
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas Endogenous Metabolite
More
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 61445-54-3
-
Peso molecular 1671.94
-
Fòrmula C78H122N22O19
-
Sequence
{Pyr}-Leu-Tyr-Gln-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu
-
Sequence Shortening
{Pyr}-LYQNKPRRPYIL
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)